TrialCancer2012

Clinical trial results of the HER-2/neu (E75) vaccine to prevent breast cancer recurrence in high-risk patients: from US Military Cancer Institute Clinical Trials Group Study I-01 and I-02.

Elizabeth A Mittendorf et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.